Literature DB >> 10347753

Liposomes: from biophysics to the design of peptide vaccines.

F Frézard1.   

Abstract

Liposomes (lipid-based vesicles) have been widely studied as drug delivery systems due to their relative safety, their structural versatility concerning size, composition and bilayer fluidity, and their ability to incorporate almost any molecule regardless of its structure. Liposomes are successful in inducing potent in vivo immunity to incorporated antigens and are now being employed in numerous immunization procedures. This is a brief overview of the structural, biophysical and pharmacological properties of liposomes and of the current strategies in the design of liposomes as vaccine delivery systems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10347753     DOI: 10.1590/s0100-879x1999000200006

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  13 in total

1.  Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.

Authors:  Roma Sinha; Jayeeta Roychoudhury; Partha Palit; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Stable, biocompatible lipid vesicle generation by solvent extraction-based droplet microfluidics.

Authors:  Shia-Yen Teh; Ruba Khnouf; Hugh Fan; Abraham P Lee
Journal:  Biomicrofluidics       Date:  2011-12-09       Impact factor: 2.800

3.  Ion quantification in liposomal drug products using high performance liquid chromatography.

Authors:  Jiewei Wu; Rachael M Crist; Scott E McNeil; Jeffrey D Clogston
Journal:  J Pharm Biomed Anal       Date:  2018-11-22       Impact factor: 3.935

Review 4.  Liposomes in tissue engineering and regenerative medicine.

Authors:  Nelson Monteiro; Albino Martins; Rui L Reis; Nuno M Neves
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

5.  Novel Adjuvant Based on the Pore-Forming Protein Sticholysin II Encapsulated into Liposomes Effectively Enhances the Antigen-Specific CTL-Mediated Immune Response.

Authors:  Rady J Laborde; Oraly Sanchez-Ferras; María C Luzardo; Yoelys Cruz-Leal; Audry Fernández; Circe Mesa; Liliana Oliver; Liem Canet; Liane Abreu-Butin; Catarina V Nogueira; Mayra Tejuca; Fabiola Pazos; Carlos Álvarez; María E Alonso; Ieda M Longo-Maugéri; Michael N Starnbach; Darren E Higgins; Luis E Fernández; María E Lanio
Journal:  J Immunol       Date:  2017-03-03       Impact factor: 5.422

6.  Effect of monovalent ion adsorption on the electric charge of phosphatidylcholine - decylamine liposomal membranes.

Authors:  Joanna Kotyńska; Izabela Dobrzyńska; Zbigniew Artur Figaszewski
Journal:  J Bioenerg Biomembr       Date:  2009-01-13       Impact factor: 2.945

7.  Effects of Liposomes Contained in Thermosensitive Hydrogels as Biomaterials Useful in Neural Tissue Engineering.

Authors:  Yusser Olguín; Cristian Campos; Javiera Catalán; Luís Velásquez; Fernando Osorio; Iván Montenegro; Alejandro Madrid; Cristian Acevedo
Journal:  Materials (Basel)       Date:  2017-09-22       Impact factor: 3.623

Review 8.  Nano-Microparticle Platforms in Developing Next-Generation Vaccines.

Authors:  Giuseppe Cappellano; Hugo Abreu; Chiara Casale; Umberto Dianzani; Annalisa Chiocchetti
Journal:  Vaccines (Basel)       Date:  2021-06-05

9.  The Vacuolar Pathway in Macrophages Plays a Major Role in Antigen Cross-Presentation Induced by the Pore-Forming Protein Sticholysin II Encapsulated Into Liposomes.

Authors:  Yoelys Cruz-Leal; Daniel Grubaugh; Catarina V Nogueira; Isbel Lopetegui-González; Anaixis Del Valle; Felipe Escalona; Rady J Laborde; Carlos Alvarez; Luis E Fernández; Michael N Starnbach; Darren E Higgins; María E Lanio
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

10.  The immunogenicity of the liposome-associated outer membrane proteins (OMPs) of Moraxella catarrhalis.

Authors:  Daria Augustyniak; Józef Mleczko; Jan Gutowicz
Journal:  Cell Mol Biol Lett       Date:  2009-10-22       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.